drugset / Trial / NCT02381652
Repeat Injection of Cingal® for Osteoarthritis of the Knee
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the safety of an injection of Cingal® in subjects with Osteoarthritis (OA) of the knee who participated in Cingal 13-01, and who received either a Cingal, Monovisc, or saline injection in the 13-01 study. The safety evaluation will be done by a through examination of the incidence of adverse events and physical examination of the knee.
Timeline
- Start
- 2015-02
- Primary completion
- 2015-04
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hyaluronic Acid | Other / unclassified | 88 mg | Other |
| Subject | Triamcinolone Hexacetonide | Other / unclassified | 18 mg | Other |